Xvivo Perfusion: Second XPS to China

Research Note

2019-09-18

09:04

Xvivo shared positive news today, reporting that they have sold an XPS to China’s second largest lung transplant clinic. We are encouraged by the progress made in the Chinese market, but chose to take a conservative stance until a clearer way forward is known. Today’s news will not affect our valuation of Xvivo.

AN

Arvid Necander

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.